Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

Stock factor profile

Arvee Laboratories (India) Ltd

ARVEE · Commodities · Chemicals & Petrochemicals

Arvee Laboratories (India) Ltd. provides chemical products, which includes polymer modifiers, contrast media and drug intermediates. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2018-02-22. The firm is primarily engaged in the manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates. The Company’s Polymer Modifiers include 5-Sulfoisophthalic Acid Mono Sodium Salt, Dimethyl 5-Sodiosulfoisophthalate and 5-Sulfoisophthalic Acid Mono Lithium Salt. Its Contrast Media Intermediates include 5-Nitroisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, Monomethyl 5-Nitroisophthalate, 3,5-Diamino Benzoic Acid, Dimethyl 5-Aminoisophthalate and 3,5-Dinitrobenzoic acid. Its Drug Intermediates include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.

Last price₹165.00
1 day-0.49%
1 month+6.15%
Model ratingLocked
Data as of03 Sep 2026

Performance

Price history

Equity review factors

Factor profile

Factor scores are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags and screen results for Arvee Laboratories (India) Ltd are part of the Wright portfolio review.

Run your free portfolio review

Fundamental snapshot

Fundamentals at a glance

Market cap171
P/E ratio64.2
Factor betaLocked
VolatilityLocked
Model scoreLocked
Screen passLocked

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.